What is access to radiation therapy? A conceptual framework and review of influencing factors
Puma Sundaresan A D , Martin R. Stockler A B and Christopher G. Milross A C
+ Author Affiliations
- Author Affiliations
A The Sydney Medical School, The University of Sydney, Sydney, NSW 2006, Australia. Email: martin.stockler@sydney.edu.au
B Clinical Trials Centre, NHMRC, Level 6, Chris O’Brien Life House, Camperdown, NSW 2050, Australia.
C Department of Radiation Oncology, Chris O’Brien Life House, Camperdown, NSW 2050, Australia. Email: chris.milross@lh.org.au
D Corresponding author. Email: psun8480@uni.sydney.edu.au
Australian Health Review 40(1) 11-18 https://doi.org/10.1071/AH14262
Submitted: 30 December 2014 Accepted: 22 April 2015 Published: 15 June 2015
Abstract
Objectives Optimal radiation therapy (RT) utilisation rates (RURs) have been defined for various cancer indications through extensive work in Australia and overseas. These benchmarks remain unrealised. The gap between optimal RUR and actual RUR has been attributed to inadequacies in ‘RT access’. We aimed to develop a conceptual framework for the consideration of ‘RT access’ by examining the literature for existing constructs and translating it to the context of RT services. We further aimed to use this framework to identify and examine factors influencing ‘RT access’.
Methods Existing models of health care access were reviewed and used to develop a multi-dimensional conceptual framework for ‘RT access’. A review of the literature was then conducted to identify factors reported to affect RT access and utilisation. The electronic databases searched, the host platform and date range of the databases searched were Ovid MEDLINE, 1946 to October 2014 and PsycINFO via OvidSP,1806 to October 2014.
Results The framework developed demonstrates that ‘RT access’ encompasses opportunity for RT as well as the translation of this opportunity to RT utilisation. Opportunity for RT includes availability, affordability, adequacy (quality) and acceptability of RT services. Several factors at the consumer, referrer and RT service levels affect the translation of this opportunity for RT to actual RT utilisation.
Conclusion ‘Access’ is a term that is widely used in the context of health service related research, planning and political discussions. It is a multi-faceted concept with many descriptions. We propose a conceptual framework for the consideration of ‘RT access’ so that factors affecting RT access and utilisation may be identified and examined. Understanding these factors, and quantifying them where possible, will allow objective evaluation of their impact on RT utilisation and guide implementation of strategies to modify their effects.
What is known about the topic? It is well documented that the use of RT in Australia is well below evidence-based benchmarks. The shortfall in the use of RT has been attributed to problems with access to treatment services. Although considerable attention has been directed (rightly) towards addressing infrastructure needs, access to RT is more than just supply of services. There is currently no specific framework for RT access to comprehensively consider and examine other factors influencing the use of RT. The existing international literature addresses some of the influencing factors. However, there is a need for a detailed review of all actual and potential influencers of RT utilisation.
What does this paper add? This paper presents a conceptual framework for the specific consideration of access to RT. A detailed review of various factors affecting access and utilisation of RT has been performed using the aforementioned conceptual framework. To our knowledge this is the first such review and hence we are confident that it adds to the existing international literature on this subject.
What are the implications for practitioners? The topic of improving consumers’ access to RT is of relevance locally, in Australia, as well as internationally. We feel that the RT access framework proposed herein will be of interest and use to those involved in health services research, delivery and policy, especially those involved with the planning and delivering of cancer services. In addition to compiling evidence on the subject, the review of factors influencing RT utilisation highlights and proposes areas for future translational and implementation research in the areas of health services and treatment-related decision making.
References
[1] Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment. Cancer 2005; 104 1129–37.| The role of radiotherapy in cancer treatment.Crossref | GoogleScholarGoogle Scholar | 16080176PubMed |
[2] Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence. Cancer 2004; 101 657–70.
| Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence.Crossref | GoogleScholarGoogle Scholar | 15305395PubMed |
[3] Delaney G, Barton M, Jacob S, Jalaludin B. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol 2003; 4 120–8.
| A model for decision making for the use of radiotherapy in lung cancer.Crossref | GoogleScholarGoogle Scholar | 12573354PubMed |
[4] Delaney G, Jacob S, Barton M. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I–malignancies of the cervix, ovary, vagina and vulva. Cancer 2004; 101 671–81.
| Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I–malignancies of the cervix, ovary, vagina and vulva.Crossref | GoogleScholarGoogle Scholar | 15305396PubMed |
[5] Delaney G, Jacob S, Barton M. Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma. Cancer 2005; 103 2216–27.
| Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma.Crossref | GoogleScholarGoogle Scholar | 15856428PubMed |
[6] Delaney G, Jacob S, Barton M. Estimating the optimal radiotherapy utilization for carcinoma of the central nervous system, thyroid carcinoma, and carcinoma of unknown primary origin from evidence-based clinical guidelines. Cancer 2006; 106 453–65.
| Estimating the optimal radiotherapy utilization for carcinoma of the central nervous system, thyroid carcinoma, and carcinoma of unknown primary origin from evidence-based clinical guidelines.Crossref | GoogleScholarGoogle Scholar | 16355366PubMed |
[7] Delaney GP, Jacob S, Barton MB. Estimation of an optimal radiotherapy utilization rate for gynaecological carcinoma: part II–carcinoma of the endometrium. Cancer 2004; 101 682–92.
| Estimation of an optimal radiotherapy utilization rate for gynaecological carcinoma: part II–carcinoma of the endometrium.Crossref | GoogleScholarGoogle Scholar |
[8] Delaney GP, Jacob S, Barton MB. Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignancies. Cancer 2005; 103 462–73.
| Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignancies.Crossref | GoogleScholarGoogle Scholar |
[9] Delaney GP, Jacob S, Featherstone C, Barton MB. Radiotherapy in cancer care: estimating the optimal utilisation from a review of evidence based clinical guidelines. Sydney: Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital; 2003. Available at: http://canceraustralia.gov.au/sites/default/files/publications/radiotherapyreport1_504af01e8daf0.pdf [verified October 2014].
[10] Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. An evidence based estimate of the appropriate radiotherapy utilization rate for prostate cancer. Int J Radiat Oncol Biol Phys 2003; 55 51–63.
| An evidence based estimate of the appropriate radiotherapy utilization rate for prostate cancer.Crossref | GoogleScholarGoogle Scholar | 12504036PubMed |
[11] Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. An evidence based estimate of the appropriate radiotherapy utilization rate for colorectal cancer. Int J Radiat Oncol Biol Phys 2003; 56 1295–307.
| An evidence based estimate of the appropriate radiotherapy utilization rate for colorectal cancer.Crossref | GoogleScholarGoogle Scholar | 12873674PubMed |
[12] Featherstone C, Delaney G, Jacob S, Barton M. Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part I–lymphoma. Cancer 2005; 103 383–92.
| Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part I–lymphoma.Crossref | GoogleScholarGoogle Scholar | 15599937PubMed |
[13] Featherstone C, Delaney G, Jacob S, Barton M. Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part II–leukemia and myeloma. Cancer 2005; 103 393–401.
| Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part II–leukemia and myeloma.Crossref | GoogleScholarGoogle Scholar | 15593373PubMed |
[14] Foroudi F, Tyldesley S, Walker H, Mackillop WJ. An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer. Int J Radiat Oncol Biol Phys 2002; 53 1240–53.
| An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer.Crossref | GoogleScholarGoogle Scholar | 12128126PubMed |
[15] Delaney GP, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for melanoma. Cancer 2004; 100 1293–301.
| Estimation of an optimal radiotherapy utilization rate for melanoma.Crossref | GoogleScholarGoogle Scholar |
[16] Barton M. Radiotherapy utilization in New South Wales from 1996 to 1998. Australas Radiol 2000; 44 308–14.
| Radiotherapy utilization in New South Wales from 1996 to 1998.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3cvmt1Sltw%3D%3D&md5=104d1b99737266836c8dbba3c95bfdcfCAS | 10974725PubMed |
[17] Barton MB, Delaney GP. A decade of investment in radiotherapy in New South Wales: why does the gap between optimal and actual persist? J Med Imaging Radiat Oncol 2011; 55 433–41.
| A decade of investment in radiotherapy in New South Wales: why does the gap between optimal and actual persist?Crossref | GoogleScholarGoogle Scholar | 21843180PubMed |
[18] Williams MV, Summers ET, Drinkwater K, Barrett A. Radiotherapy dose fractionation, access and waiting times in the countries of the UK in 2005. Clin Oncol 2007; 19 273–86.
| Radiotherapy dose fractionation, access and waiting times in the countries of the UK in 2005.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2szgsFygtw%3D%3D&md5=200fca210b75618c987552b3834d2057CAS |
[19] Kerba M, Miao Q, Zhang-Salomons J, Mackillop W. Defining the need for prostate cancer radiotherapy in the general population: a criterion-based benchmarking approach. Clin Oncol 2010; 22 801–9.
| Defining the need for prostate cancer radiotherapy in the general population: a criterion-based benchmarking approach.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3cbmslSrsQ%3D%3D&md5=0f7e8858409babc6cbfccd429bad3b59CAS |
[20] Åsli LM, Kvaløy SO, Jetne V, Myklebust TÅ, Levernes SG, Tveit KM, Green TO, Johannesen TB. Utilization of radiation therapy in Norway after the implementation of the national cancer plan: a national, population-based study. Int J Radiat Oncol Biol Phys 2014; 90 707–14.
| Utilization of radiation therapy in Norway after the implementation of the national cancer plan: a national, population-based study.Crossref | GoogleScholarGoogle Scholar | 25160610PubMed |
[21] Tyldesley S, McGahan C. Utilisation of radiotherapy in rural and urban areas in British Columbia compared with evidence-based estimates of radiotherapy needs for patients with breast, prostate and lung cancer. Clin Oncol 2010; 22 526–32.
| Utilisation of radiotherapy in rural and urban areas in British Columbia compared with evidence-based estimates of radiotherapy needs for patients with breast, prostate and lung cancer.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3cjmslWqsA%3D%3D&md5=1e2db351b93f4d01cc82da7e72f17f98CAS |
[22] Aday LA, Anderson R. Equity of access to medical care: a conceptual and empirical overview. Med Care 1981; 19 4–27.
| Equity of access to medical care: a conceptual and empirical overview.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaL387ntFyqsQ%3D%3D&md5=e3ea11383607dc34cf4e346a959321f4CAS | 11643688PubMed |
[23] Penchansky R, Thomas J. The concept of access. Med Care 1981; 19 127–40.
| The concept of access.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaL3M7kslahug%3D%3D&md5=09dc9a770a048a128e123f2df7e75f6dCAS | 7206846PubMed |
[24] Mooney GH. Equity in health care: confronting the confusion. Eff Health Care 1983; 1 179–85.
| 1:STN:280:DyaL2c7lvVClsw%3D%3D&md5=1dbff15ba772c603ad57a2002fd5dbfcCAS | 10310519PubMed |
[25] Rodin D, Jaffray D, Atun R, Knaul FM, Gospodarowicz M. The need to expand global access to radiotherapy. Lancet Oncol 2014; 15 378–80.
| The need to expand global access to radiotherapy.Crossref | GoogleScholarGoogle Scholar | 24694630PubMed |
[26] Radiation Oncology Tripartite Committee. Planning for the best: tripartite national strategic plan for radiation oncology 2012–2022, version 1. Sydney: The Royal Australian and New Zealand College of Radiologists; 2012.
[27] Datta NR, Samiei M, Bodis S. Radiation therapy infrastructure and human resources in low- and middle-income countries: present status and projections for 2020. Int J Radiat Oncol Biol Phys 2014; 89 448–57.
| Radiation therapy infrastructure and human resources in low- and middle-income countries: present status and projections for 2020.Crossref | GoogleScholarGoogle Scholar | 24751411PubMed |
[28] Cancer Council NSW. Improving radiotherapy: where to from here? Sydney: Cancer Council; 2009.
[29] Cancer Institute NSW. NSW cancer plan 2011–15. Sydney: Cancer Institute NSW; 2010.
[30] Rosenblatt E, Izewska J, Anacak Y, Pynda Y, Scalliet P, Boniol M, Autier P. Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database. Lancet Oncol 2013; 14 e79–86.
| Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database.Crossref | GoogleScholarGoogle Scholar | 23352499PubMed |
[31] Donabedian A. Models for organizing the delivery of personal health services and criteria for evaluating them. Milbank Mem Fund Q 1972; 50 103–54.
| Models for organizing the delivery of personal health services and criteria for evaluating them.Crossref | GoogleScholarGoogle Scholar |
[32] Gulliford M, Figueroa-Munoz J, Morgan M, Hughes D, Gibson B, Beech R, Hudson M. What does ‘access to health care’ mean? J Health Serv Res Policy 2002; 7 186–8.
| What does ‘access to health care’ mean?Crossref | GoogleScholarGoogle Scholar | 12171751PubMed |
[33] Gulliford M. Modernizing concepts of access and equity. Health Econ Policy Law 2009; 4 223–30.
| Modernizing concepts of access and equity.Crossref | GoogleScholarGoogle Scholar | 19250604PubMed |
[34] McIntyre D, Thiede M, Birch S. Access as a policy-relevant concept in low and middle-income countries. Health Econ Policy Law 2009; 4 179–93.
| Access as a policy-relevant concept in low and middle-income countries.Crossref | GoogleScholarGoogle Scholar | 19187569PubMed |
[35] Mooney G. Is it not time for health economists to re-think equity and access? Health Econ Policy Law 2009; 4 209–21.
| Is it not time for health economists to re-think equity and access?Crossref | GoogleScholarGoogle Scholar | 19192324PubMed |
[36] Rogers A, Flowers J, Pencheon D. Improving access needs a whole systems approach: and will be important in averting crises in the millennium winter. BMJ 1999; 319 866–7.
| Improving access needs a whole systems approach: and will be important in averting crises in the millennium winter.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1MvjsFyitw%3D%3D&md5=5e23ef95ec1ee14c244a51d6eb2e02a7CAS | 10506023PubMed |
[37] Goddard M. Access to health care services: an English policy perspective. Health Econ Policy Law 2009; 4 195–208.
| Access to health care services: an English policy perspective.Crossref | GoogleScholarGoogle Scholar | 19187570PubMed |
[38] Dixon-Woods M, Cavers D, Agarwal S, Annandale E, Arthur A, Harvey J, Hsu R, Katbamna S, Olsen R, Smith L, Riley R, Sutton AJ. Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Med Res Methodol 2006; 6 35
| Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups.Crossref | GoogleScholarGoogle Scholar | 16872487PubMed |
[39] Health Statistics and Information Systems, World Health Organization (WHO). Service availability and readiness assessment (SARA): an annual monitoring system for service delivery. Reference manual; 2013.
[40] Jaffray DA, Gospodarowicz M. Bringing global access to radiation therapy: time for a change in approach. Int J Radiat Oncol Biol Phys 2014; 89 446–7.
| Bringing global access to radiation therapy: time for a change in approach.Crossref | GoogleScholarGoogle Scholar | 24929153PubMed |
[41] Henry MJ, Jones P, Morrissy K, Matheson LM, Pitson G, Healy P, Coory M, Lynch R, Chapman A, Ashley D. Radiotherapy in the Barwon South Western Region: a rural perspective. J Med Imaging Radiat Oncol 2014; 58 612–7.
| Radiotherapy in the Barwon South Western Region: a rural perspective.Crossref | GoogleScholarGoogle Scholar | 25091019PubMed |
[42] Denham JW. How do we bring an acceptable level of radiotherapy services to a dispersed population? Australas Radiol 1995; 39 171–3.
| How do we bring an acceptable level of radiotherapy services to a dispersed population?Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2MzivFSkuw%3D%3D&md5=870a2c721edb580c398f74cf327fcd09CAS | 7605324PubMed |
[43] Khor R, Bressel M, Tai KH, Ball D, Duchesne G, Rose W, Tedesco J, Gill S, Fitzpatrick C, Foroudi F. Patterns of retreatment with radiotherapy in a large academic centre. J Med Imaging Radiat Oncol 2013; 57 610–6.
| Patterns of retreatment with radiotherapy in a large academic centre.Crossref | GoogleScholarGoogle Scholar | 24119278PubMed |
[44] Punglia RS, Weeks JC, Neville BA, Earle CC. Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys 2006; 66 56–63.
| Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women.Crossref | GoogleScholarGoogle Scholar | 16814955PubMed |
[45] Voti L, Richardson LC, Reis IM, Fleming LE, MacKinnon J, Coebergh JWW. Treatment of local breast carcinoma in Florida. Cancer 2006; 106 201–7.
| Treatment of local breast carcinoma in Florida.Crossref | GoogleScholarGoogle Scholar | 16311987PubMed |
[46] Pagano E, Di Cuonzo D, Bona C, Baldi I, Gabriele P, Ricardi U, Rotta P, Bertetto O, Appiano S, Merletti F, Segnan N, Ciccone G. Accessibility as a major determinant of radiotherapy underutilization: a population based study. Health Policy 2007; 80 483–91.
| Accessibility as a major determinant of radiotherapy underutilization: a population based study.Crossref | GoogleScholarGoogle Scholar | 16781002PubMed |
[47] Meden T, St. John-Larkin C, Hermes D, Sommerschield S. Relationship between travel distance and utilization of breast cancer treatment in rural northern Michigan. JAMA 2002; 287 111
| Relationship between travel distance and utilization of breast cancer treatment in rural northern Michigan.Crossref | GoogleScholarGoogle Scholar | 11754721PubMed |
[48] Gollop SJ, Kyle SM, Fancourt MW, Gilkison WT, Mosquera DA. Why Taranaki women choose to have a mastectomy when suitable for breast conservation treatment. ANZ J Surg 2009; 79 604–9.
| Why Taranaki women choose to have a mastectomy when suitable for breast conservation treatment.Crossref | GoogleScholarGoogle Scholar | 19895515PubMed |
[49] Danielson B, Winget M, Gao Z, Murray B, Pearcey R. Palliative radiotherapy for women with breast cancer. Clin Oncol 2008; 20 506–12.
| Palliative radiotherapy for women with breast cancer.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1cvps1ansg%3D%3D&md5=a39988bbc9fe674349e071e63f5e0059CAS |
[50] Lavergne MR, Johnston GM, Gao J, Dummer TJ, Rheaume DE. Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study. Palliat Med 2011; 25 101–10.
| Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study.Crossref | GoogleScholarGoogle Scholar | 20937613PubMed |
[51] Sutton DS, Kong W, Ding K, Mackillop WJ. The use of palliative radiotherapy for bone metastasis. Radiother Oncol 2010; 97 548–53.
| The use of palliative radiotherapy for bone metastasis.Crossref | GoogleScholarGoogle Scholar | 20971519PubMed |
[52] Turner MB, Shakespeare T, Chapman A. Improving access to radiotherapy for regional cancer patients: the National Radiotherapy Single Machine Unit Trial. Cancer Forum. Available at: http://search.informit.com.au/documentSummary;dn=442893761640311;res=IELHEA [verified November 2014].
[53] Peters LJ, O’Sullivan B, Giralt J, Fitzgerald TJ, Trotti A, Bernier J, Bourhis J, Yuen K, Fisher R, Rischin D. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J Clin Oncol 2010; 28 2996–3001.
| Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.Crossref | GoogleScholarGoogle Scholar | 20479390PubMed |
[54] Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML, Warren JL. Patient time costs associated with cancer care. J Natl Cancer Inst 2007; 99 14–23.
| Patient time costs associated with cancer care.Crossref | GoogleScholarGoogle Scholar | 17202109PubMed |
[55] Department of Human Services. Medicare safety net. 2014. Available at: http://www.humanservices.gov.au/customer/services/medicare/medicare-safety-net [verified October 2014].
[56] Clavarino AM, Lowe J, Carmont SA, Balanda K. The needs of cancer patients and their families from rural and remote areas of Queensland. Aust J Rural Health 2002; 10 188–95.
| The needs of cancer patients and their families from rural and remote areas of Queensland.Crossref | GoogleScholarGoogle Scholar | 12121408PubMed |
[57] Jack RH, Gulliford MC, Ferguson J, Møller H. Explaining inequalities in access to treatment in lung cancer. J Eval Clin Pract 2006; 12 573–82.
| Explaining inequalities in access to treatment in lung cancer.Crossref | GoogleScholarGoogle Scholar | 16987120PubMed |
[58] Huang J, Zhou S, Groome P, Tyldesley S, Zhang-Solomans J, Mackillop WJ. Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol 2001; 19 137–44.
| 1:STN:280:DC%2BD38%2Fgs1ShtQ%3D%3D&md5=5401f9a7325e8ca8a885c09340b152e3CAS | 11134206PubMed |
[59] Paszat LF, Mackillop WJ, Groome PA, Zhang-Salomons J, Schulze K, Holowaty E. Radiotherapy for breast cancer in Ontario: rate variation associated with region, age and income. Clin Invest Med 1998; 21 125–34.
| 1:STN:280:DyaK1c3ptFagtA%3D%3D&md5=b663641422fe4dead31fc47c684c70c3CAS | 9627766PubMed |
[60] Ashworth RE, Wu JJ, Cohen RF, Novik Y. Eliminating transportation barriers to outpatient radiation therapy for underserved patients with cancer. J. Clin. Oncol. 2014; 32 e17569
[61] Coory MD, Green AC, Stirling J, Valery PC. Survival of Indigenous and non-Indigenous Queenslanders after a diagnosis of lung cancer: a matched cohort study. Med J Aust 2008; 188 562–6.
| 18484926PubMed |
[62] Le H, Penniment M, Carruthers S, Roos D, Sullivan T, Baxi S. Radiation treatment compliance in the Indigenous population: the pilot Northern Territory experience and future directions. J Med Imaging Radiat Oncol 2013; 57 218–21.
| Radiation treatment compliance in the Indigenous population: the pilot Northern Territory experience and future directions.Crossref | GoogleScholarGoogle Scholar | 23551784PubMed |
[63] Grimison P, Phillips F, Butow P, White K, Yip D, Sardelic F, Underhill C, Tse R, Simes R, Turley K, Raymond C, Goldstein D. Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionals. Asia Pac J Clin Oncol 2013; 9 226–38.
| Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionals.Crossref | GoogleScholarGoogle Scholar | 22989350PubMed |
[64] Guidry JJ, Aday LA, Zhang D, Winn RJ. Transportation as a barrier to cancer treatment. Cancer Pract 1997; 5 361–6.
| 1:STN:280:DyaK1c%2FmtVWjsQ%3D%3D&md5=754bbf241b9159c4ffad75d62bce3f25CAS | 9397704PubMed |
[65] Lehman M, Jacob S, Delaney G, Papadatos G, Jalaludin B, Cail S, McCourt J, Wright S, O’Brien C, Barton M. Waiting times for radiotherapy: a survey of patients’ attitudes. Radiother Oncol 2004; 70 283–9.
| Waiting times for radiotherapy: a survey of patients’ attitudes.Crossref | GoogleScholarGoogle Scholar | 15064014PubMed |
[66] Palda VA, Llewellyn-Thomas HA, Mackenzie RG, Pritchard KI, Naylor CD. Breast cancer patients’ attitudes about rationing post lumpectomy radiation therapy: applicability of trade-off methods to policy-making. J Clin Oncol 1997; 15 3192–200.
| 1:STN:280:DyaK2svns1Wjtg%3D%3D&md5=6a1abf0526a0bc40e0cdd240547e36a1CAS | 9336355PubMed |
[67] Sanson-Fisher R, Girgis A, Boyes A, Bonevski B, Burton L, Cook P. The unmet supportive care needs of patients with cancer. Cancer 2000; 88 226–37.
| The unmet supportive care needs of patients with cancer.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3c%2Fos1OlsA%3D%3D&md5=c7ee0705cd31d3bdd2dc2be616c2dc4bCAS | 10618627PubMed |
[68] Li J, Girgis A. Supportive care needs: are patients with lung cancer a neglected population? Psychooncology 2006; 15 509–16.
| Supportive care needs: are patients with lung cancer a neglected population?Crossref | GoogleScholarGoogle Scholar | 16292789PubMed |
[69] White K, D’Abrew N, Katris P, O’Connor M, Emery L. Mapping the psychosocial and practical support needs of cancer patients in Western Australia. Eur J Cancer Care (Engl) 2012; 21 107–16.
| Mapping the psychosocial and practical support needs of cancer patients in Western Australia.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC387ntlKrsg%3D%3D&md5=8df05f71e541eac339c4a7ca6b35a2b6CAS |
[70] Fitch MI, Gray RE, McGowan T, Brunskill I, Steggles S, Sellick S, Bezjak A, McLeese D. Travelling for radiation cancer treatment: patient perspectives. Psychooncology 2003; 12 664–74.
| Travelling for radiation cancer treatment: patient perspectives.Crossref | GoogleScholarGoogle Scholar | 14502591PubMed |
[71] Hayman JA, Abrahamse PH, Lakhani I, Earle CC, Katz SJ. Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007; 69 1001–7.
| Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer.Crossref | GoogleScholarGoogle Scholar | 17689029PubMed |
[72] Puts MT, Monette J, Girre V, Wolfson C, Monette M, Batist G, Bergman H. Characteristics of older newly diagnosed cancer patients refusing cancer treatments. Support Care Cancer 2010; 18 969–74.
| Characteristics of older newly diagnosed cancer patients refusing cancer treatments.Crossref | GoogleScholarGoogle Scholar | 20419496PubMed |
[73] Halkett GKB, Jiwa M, O’Shea C, Smith M, Leong E, Jackson M, Meng X, Spry N. Management of cases that might benefit from radiotherapy: a standardised patient study in primary care. Eur J Cancer Care (Engl) 2012; 21 259–65.
| Management of cases that might benefit from radiotherapy: a standardised patient study in primary care.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC38vnsFGmuw%3D%3D&md5=260621fe1f32b31be4d89ac431e93955CAS |
[74] Samant RS, Fitzgibbon E, Meng J, Graham ID. Barriers to palliative radiotherapy referral: a Canadian perspective. Acta Oncol (Madr) 2007; 46 659–63.
| Barriers to palliative radiotherapy referral: a Canadian perspective.Crossref | GoogleScholarGoogle Scholar |
[75] Barnes EA, Parliament M, Hanson J, Watanabe S, Palmer JL, Bruera E. Palliative radiotherapy for patients with bone metastases: survey of primary care physicians. Radiother Oncol 2003; 67 221–3.
| Palliative radiotherapy for patients with bone metastases: survey of primary care physicians.Crossref | GoogleScholarGoogle Scholar | 12812854PubMed |
[76] Tucker TL, Samant RS, Fitzgibbon EJ. Knowledge and utilization of palliative radiotherapy by pediatric oncologists. Curr Oncol 2010; 17 48–55.
| Knowledge and utilization of palliative radiotherapy by pediatric oncologists.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3c7jt1emtA%3D%3D&md5=f38b92d20ece82e1e5c27cc121e1c495CAS | 20179803PubMed |
[77] Paul C, Carey M, Anderson A, Mackenzie L, Sanson-Fisher R, Courtney R, Clinton T. Cancer patients’ concerns regarding access to cancer care: perceived impact of waiting times along the diagnosis and treatment journey. Eur J Cancer Care (Engl) 2012; 21 321–9.
| Cancer patients’ concerns regarding access to cancer care: perceived impact of waiting times along the diagnosis and treatment journey.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC38znvFSitQ%3D%3D&md5=3778408b61031f16ae90d3ee90971443CAS |
[78] Boxer MM, Vinod SK, Shafiq J, Duggan KJ. Do multidisciplinary team meetings make a difference in the management of lung cancer Cancer 2011; 117 5112–20.
| Do multidisciplinary team meetings make a difference in the management of lung cancerCrossref | GoogleScholarGoogle Scholar | 21523766PubMed |
